Innovation for Sight
The Next Generation
Glaucoma Treatment Platform
Innovation for Sight
The Next Generation
Glaucoma Treatment Platform
The World's First Neuroprotective Glaucoma Treatment Device
GlaucoT is a smart wearable device designed for gamma rhythm entrainment in order to reduce neuroinflammation.
Benefits
Wearable tech device for "at home" treatment
Patient will use GlaucoT at home, with pleasure by their prefered time and will get rid of glaucoma. You could get pleasure of drinking coffee when you are wearing GlaucoT and treat your glaucoma!
Noninvasive Treatment
This is a simple medical consumer electronic device. You don't need to have any surgery or operation to use it so its a non-invasive treatment.
RESERVE a Meeting
RESERVE a Meeting
RESERVE a Meeting
Please make your booking for get more information either at physically at CES Eureka Park or Online
WE ARE IN IT!
EUREKA PARK
Booth # 63519
JAN 5-8, 2023
LAS VEGAS, NV & DIGITAL
CES 2023
RESERVE a Meeting
RESERVE a Meeting
WE ARE IN IT!
JAN 5-8, 2023
LAS VEGAS, NV & DIGITAL
We are attending to Eureka Park™ at CES 2023. Eureka Park™ at CES® is where new ideas are funded. It’s the buzzworthy startup arena that provides a unique opportunity to launch a new product, service or idea. We are looking forward to meeting with the potential customers and investers at Eureka Park.
EIT Health
RESERVE a Meeting
Start Up Stadium BIO USA
We are really excited to be selected for the EIT Health 2022 Catapult Program. The programme recognises and awards the very best business concepts, fast-tracking start-ups to become part of the EIT Health Community of world-leading companies.
Start Up Stadium BIO USA
Selected to BIO International Con.
Start Up Stadium BIO USA
It is our pleasure to announce that our start-up “GlaucoT” has been selected among 16 companies to present at the Start-Up Stadium event from hundreds of startups and entrepreneurs from around the world. We will have the opportunity to introduce Glaucot and our innovation “Wearable Glaucoma Treatment Device” to key members of the investment community, venture philanthropy groups, strategic partners, and non-dilutive capital.
Selected to BIO International Con.
Selected to BIO International Con.
Selected to BIO International Con.
Glaucot is Number 1
Selected to BIO International Con.
Selected to BIO International Con.
GlaucoT won first place out of 471 projects participating in TET R&D Project Brokerage Event organized by TET - Electrical and Electronics Exporters Association
https://www.tetprojepazari.org/tr/Default.aspx
Göz Tansiyonu (glokom) Tedavisi için geliştirdiğimiz GlaucoT projemiz TET Tarafından düzenlenen 9. Proje Pazarın etkinliğinde 471 proje arasından birinci seçildi. Tüm ekibimize ve bu projede bize destek olan TTGV HIT programına teşekkür ediyoruz. #glokom #glaucoma #ttgv #immib
TTGV HIT Acceleration Program
TTGV HIT Acceleration Program
TTGV HIT Acceleration Program
GlaucoT, World First, noninvasive neuroprotective Glacuoma treatment device on the way, pleasure to get support from TTGV HIT
GlaucoT, dünyanın ilk noninvaziv nöroprotektif Glokom (Göz Tansiyonu) tedavi cihazı yolda, TTGV HIT'den destek almak gurur verici
#TeknolojiÜretenTürkiye #TTGV #glaucoma #glokom #göztansiyonu #innovation #HitProgramı #GlaucoT
Acıbadem Incubator
TTGV HIT Acceleration Program
TTGV HIT Acceleration Program
Our Co-founder Dr. Abdülkadir Oduncu has attended immense training at Acıbadem Incubation center for GlaucoT project commercialization